Clinical Trial Update: Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab, gemcitabine, and oxaliplatin followed by either surgery or external-beam radiation therapy with capecitabine in locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• Xeloda (capecitabine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-23